Company · CIK 0001860871 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Tevogen Inc. · TVGN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 AForm 4 → | Sep 16, 7:54 pm EDT | Ryan H. SaadiChief Executive Officer, Director, 10% Owner | 8,000,000 | — | — | 11,705,689 | — | |
| Sep 14, 2026 AForm 4 → | Sep 16, 7:54 pm EDT | Kirti DesaiChief Financial Officer | 750,000 | — | — | 992,983 | — | |
| Sep 11, 2026 AForm 4 → | Sep 15, 8:08 pm EDT | Keow Lin GohDirector | 75,000 | — | — | 123,678 | — | |
| Sep 11, 2026 AForm 4 → | Sep 15, 8:05 pm EDT | Susan M PodlogarDirector | 75,000 | — | — | 123,678 | — | |
| Sep 11, 2026 AForm 4 → | Sep 15, 8:05 pm EDT | Victor J. SordilloDirector | 75,000 | — | — | 126,539 | — | |
| Sep 11, 2026 AForm 4 → | Sep 15, 8:04 pm EDT | Jeffrey L. FeikeDirector | 75,000 | — | — | 131,435 | — | |
| Sep 11, 2026 AForm 4 → | Sep 15, 8:04 pm EDT | Curtis L. PattonDirector | 75,000 | — | — | 139,192 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 5:31 pm EDT | Victor J. SordilloDirector | 40,000 | — | — | 51,539 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 5:31 pm EDT | Ryan H. SaadiChief Executive Officer, Director, 10% Owner | 1,220,000 | — | — | 3,705,689 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 5:31 pm EDT | Susan M PodlogarDirector | 40,000 | — | — | 48,678 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 5:31 pm EDT | Curtis L. PattonDirector | 40,000 | — | — | 64,192 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 5:30 pm EDT | Keow Lin GohDirector | 40,000 | — | — | 48,678 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 5:30 pm EDT | Jeffrey L. FeikeDirector | 40,000 | — | — | 56,435 | — | |
| Jul 10, 2026 AForm 4 → | Jul 10, 5:30 pm EDT | Kirti DesaiChief Financial Officer | 40,000 | — | — | 242,983 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.